先進數通(300541.SZ):2名股東減持期屆滿 合計減持700.99萬股
格隆匯3月25日丨先進數通(300541.SZ)公佈,2020年3月24日,公司收到股東陳東輝、韓燕嬰分別出具的《股東股份減持計劃實施進展告知函》。截至公告披露日,股東陳東輝、韓燕嬰此次減持計劃期限屆滿。
在此次減持計劃實施時間區間內,股東陳東輝通過集中競價交易方式累計減持公司股份359.99萬股,減持股數未超過預計減持計劃的數量,減持計劃實施完畢;股東韓燕嬰通過集中競價交易方式累計減持公司股份341.0萬股,減持股數未超過預計減持計劃的數量,減持計劃期限屆滿。
此次減持後,陳東輝持有股份516.04萬股,佔總股本比例2.85%;韓燕嬰持有股份535.03萬股,佔總股本比例2.95%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.